MX2010003563A - Inhibidores de proteina cinasa de c-met. - Google Patents
Inhibidores de proteina cinasa de c-met.Info
- Publication number
- MX2010003563A MX2010003563A MX2010003563A MX2010003563A MX2010003563A MX 2010003563 A MX2010003563 A MX 2010003563A MX 2010003563 A MX2010003563 A MX 2010003563A MX 2010003563 A MX2010003563 A MX 2010003563A MX 2010003563 A MX2010003563 A MX 2010003563A
- Authority
- MX
- Mexico
- Prior art keywords
- protein kinase
- met protein
- kinase inhibitors
- compounds
- formula
- Prior art date
Links
- 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 title abstract 2
- 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 title abstract 2
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97730507P | 2007-10-03 | 2007-10-03 | |
| PCT/US2008/078239 WO2009045992A2 (en) | 2007-10-03 | 2008-09-30 | C-met protein kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003563A true MX2010003563A (es) | 2010-06-02 |
Family
ID=40512401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003563A MX2010003563A (es) | 2007-10-03 | 2008-09-30 | Inhibidores de proteina cinasa de c-met. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8481524B2 (enExample) |
| EP (1) | EP2205589B1 (enExample) |
| JP (1) | JP2010540649A (enExample) |
| CN (1) | CN101990538A (enExample) |
| AT (1) | ATE502935T1 (enExample) |
| AU (1) | AU2008308900A1 (enExample) |
| CA (1) | CA2701124A1 (enExample) |
| DE (1) | DE602008005786D1 (enExample) |
| ES (1) | ES2361650T3 (enExample) |
| MX (1) | MX2010003563A (enExample) |
| NZ (1) | NZ584311A (enExample) |
| WO (1) | WO2009045992A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012506381A (ja) * | 2008-10-21 | 2012-03-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | ｃ−ＭＥＴタンパク質キナーゼ阻害剤 |
| ES2534516T3 (es) | 2010-01-07 | 2015-04-23 | E.I. Du Pont De Nemours And Company | Compuestos heterocíclicos fungicidas |
| EP2588107A1 (en) | 2010-07-01 | 2013-05-08 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| US9573881B2 (en) | 2012-12-25 | 2017-02-21 | Nippon Soda Co., Ltd. | Halogenated aniline and method for producing same |
| CN103242216A (zh) * | 2013-05-07 | 2013-08-14 | 兰州梦唐精细化工有限公司 | N- Boc -六氢-5-氧代环戊[C]并吡咯的合成方法 |
| US9896436B2 (en) | 2014-09-16 | 2018-02-20 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| CA2961525A1 (en) | 2014-09-16 | 2016-03-24 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| EP3229836B1 (en) | 2014-12-09 | 2019-11-13 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Human monoclonal antibodies against axl |
| WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2539726A1 (en) * | 2003-09-24 | 2005-05-06 | Vertex Pharmaceuticals Incorporated | 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| US7169781B2 (en) * | 2003-10-17 | 2007-01-30 | Hoffmann-La Roche Inc. | Imidazole derivatives and their use as pharmaceutical agents |
| KR20090007347A (ko) * | 2006-03-22 | 2009-01-16 | 버텍스 파마슈티칼스 인코포레이티드 | 증식성 장애의 치료를 위한 ｃ-ＭＥＴ 단백질 키나제 억제제 |
-
2008
- 2008-09-30 DE DE602008005786T patent/DE602008005786D1/de active Active
- 2008-09-30 EP EP08835773A patent/EP2205589B1/en not_active Not-in-force
- 2008-09-30 MX MX2010003563A patent/MX2010003563A/es active IP Right Grant
- 2008-09-30 AU AU2008308900A patent/AU2008308900A1/en not_active Abandoned
- 2008-09-30 CA CA2701124A patent/CA2701124A1/en not_active Abandoned
- 2008-09-30 AT AT08835773T patent/ATE502935T1/de not_active IP Right Cessation
- 2008-09-30 NZ NZ584311A patent/NZ584311A/en not_active IP Right Cessation
- 2008-09-30 ES ES08835773T patent/ES2361650T3/es active Active
- 2008-09-30 JP JP2010528066A patent/JP2010540649A/ja active Pending
- 2008-09-30 CN CN2008801170093A patent/CN101990538A/zh active Pending
- 2008-09-30 WO PCT/US2008/078239 patent/WO2009045992A2/en not_active Ceased
-
2010
- 2010-03-31 US US12/751,016 patent/US8481524B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2701124A1 (en) | 2009-04-09 |
| EP2205589A2 (en) | 2010-07-14 |
| WO2009045992A3 (en) | 2009-06-04 |
| US8481524B2 (en) | 2013-07-09 |
| AU2008308900A1 (en) | 2009-04-09 |
| DE602008005786D1 (de) | 2011-05-05 |
| EP2205589B1 (en) | 2011-03-23 |
| ATE502935T1 (de) | 2011-04-15 |
| ES2361650T3 (es) | 2011-06-21 |
| JP2010540649A (ja) | 2010-12-24 |
| NZ584311A (en) | 2012-03-30 |
| WO2009045992A2 (en) | 2009-04-09 |
| CN101990538A (zh) | 2011-03-23 |
| US20110136789A1 (en) | 2011-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL200793A0 (en) | Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases | |
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| NO20084435L (no) | C-MET proteinkinaseinhibitorer | |
| MX2009010037A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
| MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
| MX2009009592A (es) | Aminopiridinas utiles como inhibidores de proteinas cinasas. | |
| TW200740803A (en) | Heterocyclic derivatives as modulators of ion channels | |
| MX2009006345A (es) | Compuestos utiles como inhibidores de proteina cinasa. | |
| MX2009011811A (es) | Aminopirimidinas utiles como inhibidores de cinasa. | |
| NO20082508L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
| MX2009002842A (es) | Inhibidores heterociclicos de c-met y usos de los mismos. | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| MX2009011810A (es) | Tiazoles y pirazoles utiles como inhibidores de cinasa. | |
| MX2009012719A (es) | Tiazoles y pirazoles utiles como inhibidores de cinasa. | |
| MX2009006690A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| IL197080A0 (en) | Pyrimidone compounds as gsk-3 inhibitors | |
| MX2010003865A (es) | Aril amidas utiles como inhibidores de canales de sodio dependientes de voltaje. | |
| CA2818187C (en) | Bromodomain inhibitors and uses thereof | |
| MX2010003866A (es) | Heteroaril amidas utiles como inhibidores de canales de sodio dependientes de voltaje. | |
| MX2010003864A (es) | Amidas utiles como inhibidores de canales de sodio dependientes de voltaje. | |
| MX2009010127A (es) | Compuestos utiles como inhibidores de janus cinasas. | |
| MX2009004771A (es) | Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa. | |
| ATE502935T1 (de) | C-met-proteinkinasehemmer | |
| MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
| ZA201003352B (en) | Heterocyclic derivatives as modulators of ion channels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |